Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Thoracic 1 Sarcoma 1 Head & Neck 1 Gastrointestinal 1 CNS 1

Conditions

Neoplasms 1 Chordoma 1

Interventions

Doxorubicin 40 Radiotherapy 30 Ifosfamide 28 Vincristine 27 Cyclophosphamide 24 Imatinib Mesylate 20 Etoposide 20 Dactinomycin 14 Radiation 13 Filgrastim 11 Temozolomide 9 Sunitinib 9 Trabectedin 8 Methotrexate 8 Specimen Handling 7 Magnetic Resonance Spectroscopy 6 Granulocyte Colony-Stimulating Factor 6 Chemotherapy, Adjuvant 6 pazopanib 5 nilotinib 5 Zoledronic Acid 5 Neoadjuvant Therapy 5 Irinotecan 5 Cisplatin 5 Carboplatin 5 X-Rays 4 Vinorelbine 4 Topotecan 4 Surgical Procedures, Operative 4 Procarbazine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Protons × Sarcoma × Clear all

NCT01182779 2010-08-17

HIT-1

Heidelberg University

Phase 3 Unknown

Chordoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡